Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Residual Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06867146
What this trial is testing

MRD in PAAD Adjuvant Therapy

Who this might be right for
The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant TherapyMolecular Residual DiseasePancreatic Cancer+1 more
Peking Union Medical College Hospital 60
Not applicableLooking for participantsNCT07025785
What this trial is testing

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

Who this might be right for
Breast CancerLymph Node Metastasis
UNC Lineberger Comprehensive Cancer Center 100
Not applicableLooking for participantsNCT07524114
What this trial is testing

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Who this might be right for
Breast CancerLung CancerMelanoma+7 more
University Health Network, Toronto 7,000
Post-approval studies (Phase 4)Active Not RecruitingNCT05185258
What this trial is testing

Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study

Who this might be right for
Psoriasis VulgarisPsoriasisSkin Diseases+2 more
Aarhus University Hospital 12
Not applicableLooking for participantsNCT06401421
What this trial is testing

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Who this might be right for
Breast Cancer
Exact Sciences Corporation 1,800
Not applicableLooking for participantsNCT06230185
What this trial is testing

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Who this might be right for
TNBC - Triple-Negative Breast CancerMinimal Residual Disease
Personalis Inc. 422
Not applicableWithdrawnNCT05860543
What this trial is testing

Clinical Performance Evaluation of the C2i Test

Who this might be right for
Muscle Invasive Bladder Cancer
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT03537560
What this trial is testing

Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Chang Gung Memorial Hospital 334
Testing effectiveness (Phase 2)Looking for participantsNCT07069595
What this trial is testing

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

Who this might be right for
Breast CancerResidual DiseaseTriple Negative Breast Cancer (TNBC)+1 more
UNC Lineberger Comprehensive Cancer Center 78
Not applicableEnded earlyNCT05221827
What this trial is testing

Clinical Performance Evaluation of the C2i-Test

Who this might be right for
Muscle-Invasive Bladder Carcinoma
C2i Genomics 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07357532
What this trial is testing

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

Who this might be right for
Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute 44
Not applicableLooking for participantsNCT05965024
What this trial is testing

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 377
Not applicableActive Not RecruitingNCT04599309
What this trial is testing

Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
CancerHead and Neck Squamous Cell CarcinomaHead and Neck Cancer
University Health Network, Toronto 35
Not applicableStudy completedNCT06654622
What this trial is testing

Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer

Who this might be right for
Colo-rectal CancerColorectal Cancer Recurrent
City of Hope Medical Center 175
Large-scale testing (Phase 3)Looking for participantsNCT06332274
What this trial is testing

TislelizUMaB in canceR Patients With molEcuLar residuaL Disease

Who this might be right for
CancerLung CancerColo-rectal Cancer+2 more
Gustave Roussy, Cancer Campus, Grand Paris 717
Not applicableNot Yet RecruitingNCT07799649
What this trial is testing

CtDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 150
Testing effectiveness (Phase 2)Looking for participantsNCT07631052
What this trial is testing

Capecitabine in ER+/HER2-negative Breast Cancer

Who this might be right for
ER-positive, HER2-negative Breast CancerBreast Cancer Stage IBreast Cancer Stage II+1 more
University Health Network, Toronto 15
Not applicableUnknownNCT06456112
What this trial is testing

Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

Who this might be right for
Cervical Cancer
Anhui Provincial Hospital 83
Testing effectiveness (Phase 2)Looking for participantsNCT05388149
What this trial is testing

Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease

Who this might be right for
Breast CancerHER2-positive Breast Cancer
University Health Network, Toronto 15
Not applicableLooking for participantsNCT07214532
What this trial is testing

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement)
Natera, Inc. 725
Next Page